Insight Molecular Diagnostics (IMDX) Non-cash Items (2017 - 2026)

Insight Molecular Diagnostics has disclosed Non-cash Items across 8 years of filings, most recently posting $635000.0 for Q1 2026.

• Non-cash Items for Q1 2026 came in at $635000.0, up 360.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $635000.0 (up 360.14% YoY), and the FY2025 annual result was $8.5 million, up 3370.33% from the prior year.
• Non-cash Items came in at $635000.0 for Q1 2026 at Insight Molecular Diagnostics, down from $8.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $8.5 million in Q4 2025 to a low of $24000.0 in Q3 2024.
• The 3-year median for Non-cash Items is $206500.0 (2024), against an average of $1.3 million.
• Peak annual rise in Non-cash Items reached 2058.33% in 2025, while the deepest fall reached 48.18% in 2025.
• Insight Molecular Diagnostics' Non-cash Items stood at $24000.0 in 2024, then soared by 35470.83% to $8.5 million in 2025, then sank by 92.56% to $635000.0 in 2026.
• The last three Non-cash Items figures came in at $635000.0 (Q1 2026), $8.5 million (Q4 2025), and $518000.0 (Q3 2025), per Business Quant data.